ImmunityBio
IBRX
$5.82
Share price
-2.27%
Change (1 day)
112.59%
Change (1 year)
Categories
ImmunityBio (IBRX) - P/B ratio
P/B ratio as of June 2024 : -5.97
According to ImmunityBio's latest financial reports the company has a price-to-book ratio of -5.97.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ImmunityBio - P/B ratio (from 2021 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -5.72 | 26.79% |
| 2022-12-31 | -4.51 | -54.5% |
| 2021-12-31 | -9.92 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.54 | -125.76% | 🇺🇸 USA |